Barclays initiated coverage of Amphenol (APH) with an Equal Weight rating and $120 price target Unlike many peers, Amphenol operates through a unique decentralized business model, enabling its 140 subsidiary companies to react quickly to market changes, the analyst tells investors in a research note. The firm believes strong organic growth and the $10.5B CCS division acquisition have driven year-to-date share performance.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APH:
- Amphenol price target raised to $145 from $120 at UBS
- Amphenol price target raised to $139 from $124 at Goldman Sachs
- Amphenol price target raised to $145 from $125 at Citi
- AI Isn’t Dead – It’s Evolving from the Brains to the Body
- Amphenol Secures $4 Billion for CommScope Acquisition